retatrutide transformation Retatrutide: 10 SHOCKING Things Nobody

Which one do other customers trust

Nature 2003

NAION vision loss Ileus

To minimize the impact of bias, we included both male and female mice (mutants and respective gender controls) in the different experiments, as reported in the figure legends

Isei MO, Stevens D, Kamunde C

Retatrutide Side Effects Are Similar to Existing Diabetes and Obesity Injectables The most common side effects for retatrutide were: Nausea (16 to 27 percent of participants, depending on dosage, compared with 3.7 percent of those taking a placebo) Diarrhea (19 to 23 percent, compared with 5 percent taking a placebo) Vomiting (16 to 18 percent, compared with 2 percent taking a placebo) Nerve issues (2 to 4 percent, compared with none taking a placebo) Between 2 and 5 percent of participants on retatrutide stopped taking it before the trial ended, with a greater risk of stopping among those who took the highest dose